Cognitive Screening in MS: Practical Strategies and Modern Approaches
NeuroFrontiersCognitive Screening in MS: Practical Strategies and Modern Approaches
Elizabeth S. Gromisch, PhD
Advancing Cognitive Screening and Monitoring in MS
NeuroFrontiersAdvancing Cognitive Screening and Monitoring in MS
Elizabeth S. Gromisch, PhD
How Real-World Adherence Is Shaping Preventive Migraine Treatment
NeuroFrontiersHow Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiersVagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiersRethinking Vestibular Migraine in Clinical Practice
Insights on Migraine Care Disparities from OVERCOME
AudioAbstractsInsights on Migraine Care Disparities from OVERCOME
Ryan Quigley
- advertisement
- 3 questions
- advertisement
Expandable Cages Enhance Minimally Invasive Spinal Fusion
Medical Industry FeatureExpandable Cages Enhance Minimally Invasive Spinal Fusion
Ibrahim Hussain, M.D.
Engaging Neuroplasticity in Depression with Cognitive-Emotional Training
Medical Industry FeatureEngaging Neuroplasticity in Depression with Cognitive-Emotional Training
Charles Turck, PharmD, BCPS, BCCCP
Brian Iacoviello, PhD
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Medical Industry FeatureFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Charles Turck, PharmD, BCPS, BCCCP
Joseph Goldberg, MD
Neuroplasticity: A Potential Target for the Treatment of Depression
Medical Industry FeatureNeuroplasticity: A Potential Target for the Treatment of Depression
Charles Turck, PharmD, BCPS, BCCCP
Madhukar H. Trivedi, MD
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry FeatureBreakthrough Technology Improves Concussion Assessment and Player Safety
Thomas S. Bottiglieri, DO
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Marwan Sabbagh, MD, FAAN, CCR
Cara Leahy, DO
David Weisman, MD
- 05/28/2026
- 05/28/2026
- 05/28/2026
- 05/28/2026
- 05/27/2026
- 05/27/2026